GNH USA

Europe — EMA

Methotrexate Accord

GNH USA supplies Methotrexate Accord (Methotrexate), a folate antagonist for rheumatoid arthritis, psoriasis, and certain cancers.

Methotrexate

Request sourcing

1
Pack/s

What is Methotrexate?

Methotrexate, the active ingredient in Methotrexate Accord, is an antimetabolite (folate antagonist) presented as a parenteral formulation for intraarterial, intramuscular, and intravenous use. It is employed in the management of rheumatoid arthritis, psoriasis, certain cancers, and ectopic pregnancy.

GNH USA supplies Methotrexate Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies, and transplant centres worldwide.

What is Methotrexate used for?

Methotrexate is a folate antagonist used across autoimmune and oncologic disease pathways.

- Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: limits skin cell proliferation and improves plaque lesions. - Acute lymphoblastic leukemia: interferes with malignant cell replication. - Non‑Hodgkin lymphoma: induces tumor cell death. - Breast cancer: enhances the effect of other chemotherapeutic agents. - Ectopic pregnancy: halts trophoblastic growth to allow non‑surgical resolution.

What are the side effects of Methotrexate?

Methotrexate may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea or vomiting. - Fatigue or malaise. - Mouth ulcers or sore throat. - Mild elevation of liver enzymes.

Serious or Rare Side Effects: - Severe liver toxicity or fibrosis. - Pulmonary fibrosis or interstitial pneumonitis. - Profound bone‑marrow suppression leading to pancytopenia.

What precautions apply to Methotrexate?

Careful monitoring and patient education are essential when using Methotrexate.

- Liver monitoring: perform regular liver function tests. - Hematologic monitoring: check complete blood counts frequently. - Pregnancy avoidance: contraindicated in pregnancy (Category X). - Renal function: adjust dose in patients with impaired clearance. - Folic acid supplementation: recommended to reduce mucosal toxicity. - Store at controlled room temperature: keep in the original container, protect from moisture and light.

What does Methotrexate interact with?

Methotrexate interacts with several medicines that can alter its safety or efficacy.

Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase risk of renal toxicity. - Trimethoprim‑sulfamethoxazole: may potentiate bone‑marrow suppression. - Live vaccines: risk of uncontrolled infection.

Moderate Interactions (Monitor Closely): - Azathioprine: additive immunosuppression requiring blood‑count monitoring. - Phenytoin: may reduce methotrexate plasma levels, necessitating efficacy assessment.

Frequently asked questions

What conditions is Methotrexate Accord used to treat?+
Methotrexate Accord is indicated for rheumatoid arthritis, psoriasis, acute lymphoblastic leukemia, non‑Hodgkin lymphoma, breast cancer, and ectopic pregnancy. In each case the drug works by inhibiting cell proliferation, thereby reducing inflammation in autoimmune disease or limiting tumor growth in cancer.
How does methotrexate work in the body?+
Methotrexate blocks the enzyme dihydrofolate reductase, which is essential for producing tetrahydrofolate. Without tetrahydrofolate, cells cannot synthesize purines and thymidylate, leading to reduced DNA and RNA production. This antiproliferative effect is most pronounced in rapidly dividing cells, such as immune cells and cancer cells.
What is the usual dose of Methotrexate Accord?+
The specific dose of Methotrexate Accord is determined by the prescribing clinician based on the indication, patient weight, renal function, and treatment goals. Dosing regimens vary widely between autoimmune disorders and oncology protocols, and the prescriber will tailor the schedule to each individual patient.
Is Methotrexate Accord safe during pregnancy or breastfeeding?+
Methotrexate is classified as Pregnancy Category X, meaning it is contraindicated in pregnancy due to a high risk of fetal malformations and loss. It is also not recommended while breastfeeding because it can be excreted in milk and may harm the infant. Effective contraception is required for women of child‑bearing potential.
How do I order Methotrexate Accord from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and necessary import documentation.
How does Methotrexate Accord compare with other DMARDs?+
Methotrexate is often considered the first‑line disease‑modifying antirheumatic drug because of its proven efficacy, oral and parenteral options, and cost‑effectiveness. Compared with biologic DMARDs, it has a broader therapeutic window but requires regular laboratory monitoring for liver and marrow toxicity. Choice depends on disease severity, patient comorbidities, and response to therapy.
What are the recommended storage conditions for Methotrexate Accord?+
Methotrexate Accord should be stored at controlled room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly sealed to maintain stability throughout its shelf life.
How is Methotrexate Accord administered?+
Methotrexate Accord is supplied as a parenteral solution and can be given via intra‑arterial, intramuscular, or intravenous injection, depending on the clinical indication and prescribing protocol. Administration is performed by qualified healthcare professionals in a controlled setting.
What are the most serious risks associated with Methotrexate Accord?+
The most serious risks include severe liver toxicity, pulmonary fibrosis, and profound bone‑marrow suppression that can lead to life‑threatening infections or bleeding. Patients should be monitored closely for signs of hepatic dysfunction, respiratory symptoms, and abnormal blood counts, and treatment should be stopped if these events occur.
Who should not use Methotrexate Accord?+
Methotrexate Accord is contraindicated in pregnant women, individuals with severe liver disease, uncontrolled infections, and patients with known hypersensitivity to methotrexate or any component of the formulation. Caution is also advised for patients with renal impairment or existing bone‑marrow disorders.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Methotrexate
Route
Intraarterial Use , Intramuscular Use , Intravenou
Manufacturer
Accord Healthcare B.V.
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU